The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6–12
- 1 April 2017
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 176, 102-107
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialJournal of Neuro-Ophthalmology, 2016
- CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialJournal of Neurology, 2015
- Quality of life in idiopathic intracranial hypertension at diagnosisNeurology, 2015
- The Idiopathic Intracranial Hypertension Treatment TrialJournal of Neuro-Ophthalmology, 2014
- Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual LossJAMA, 2014
- Responsiveness of NEI VFQ-25 to Changes in Visual Acuity in Neovascular AMD: Validation Studies from Two Phase 3 Clinical TrialsInvestigative Ophthalmology & Visual Science, 2009
- Validation and Test Characteristics of a 10-Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25American Journal of Ophthalmology, 2006
- A six-item short-form survey for measuring headache impact: The HIT-6™Quality of Life Research, 2003
- Whence pseudotumor cerebri?1985
- Swelling of the optic nerve head: a staging schemeJournal of Neurology, Neurosurgery & Psychiatry, 1982